S3-Leitlinie "Magenkarzinom "- Diagnostik und Therapie der Adenokarzinome des Magens und ösophagogastralen Übergangs (AWMF-Regist.-Nr. 032-009-OL) German S3-Guideline "Diagnosis and Treatment of Esophagogastric Cancer"

[1]  A. Edwards,et al.  Psychological interventions for women with metastatic breast cancer. , 2013, The Cochrane database of systematic reviews.

[2]  J. Byron-Daniel,et al.  Exercise for the management of cancer-related fatigue in adults. , 2012, The Cochrane database of systematic reviews.

[3]  S. Kubicka,et al.  Cetuximab with irinotecan, folinic acid and 5-fluorouracil as first-line treatment in advanced gastroesophageal cancer: a prospective multi-center biomarker-oriented phase II study. , 2011, Annals of oncology : official journal of the European Society for Medical Oncology.

[4]  P. Schlag,et al.  Neoadjuvant chemotherapy compared with surgery alone for locally advanced cancer of the stomach and cardia: European Organisation for Research and Treatment of Cancer randomized trial 40954. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[5]  M. Somerfield,et al.  American society of clinical oncology/american society of hematology clinical practice guideline update on the use of epoetin and darbepoetin in adult patients with cancer. , 2010, Journal of oncology practice.

[6]  Yoon-Koo Kang,et al.  Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial , 2010, The Lancet.

[7]  Manfred Dietel,et al.  HER2 diagnostics in gastric cancer—guideline validation and development of standardized immunohistochemical testing , 2010, Virchows Archiv.

[8]  I. Song,et al.  Comparison of endoscopic ultrasonography and conventional endoscopy for prediction of depth of tumor invasion in early gastric cancer , 2010, Endoscopy.

[9]  T. Gotoda,et al.  Endoscopic resection of early gastric cancer treated by guideline and expanded National Cancer Centre criteria , 2010, The British journal of surgery.

[10]  E. Prommer,et al.  Palliative treatment of malignant ascites: profile of catumaxomab , 2010, Biologics : targets & therapy.

[11]  D. Sargent,et al.  Benefit of adjuvant chemotherapy for resectable gastric cancer: a meta-analysis. , 2010, JAMA.

[12]  M. Kris,et al.  Guideline update for MASCC and ESMO in the prevention of chemotherapy- and radiotherapy-induced nausea and vomiting: results of the Perugia consensus conference. , 2010, Annals of oncology : official journal of the European Society for Medical Oncology.

[13]  H. Christiansen,et al.  Influence of irradiated lung volumes on perioperative morbidity and mortality in patients after neoadjuvant radiochemotherapy for esophageal cancer. , 2010, International journal of radiation oncology, biology, physics.

[14]  H. Putter,et al.  Surgical treatment of gastric cancer: 15-year follow-up results of the randomised nationwide Dutch D1D2 trial. , 2010, The Lancet. Oncology.

[15]  P. Murawa,et al.  The trifunctional antibody catumaxomab for the treatment of malignant ascites due to epithelial cancer: Results of a prospective randomized phase II/III trial , 2010, International journal of cancer.

[16]  J. Ajani,et al.  Multicenter phase III comparison of cisplatin/S-1 with cisplatin/infusional fluorouracil in advanced gastric or gastroesophageal adenocarcinoma study: the FLAGS trial. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[17]  C. Compton,et al.  The American Joint Committee on Cancer: the 7th Edition of the AJCC Cancer Staging Manual and the Future of TNM , 2010, Annals of Surgical Oncology.

[18]  F. Orsi,et al.  Surgical outcome after docetaxel-based neoadjuvant chemotherapy in locally-advanced gastric cancer. , 2010, World journal of gastroenterology.

[19]  P. Butow,et al.  Shared decision making coding systems: how do they compare in the oncology context? , 2010, Patient education and counseling.

[20]  K. Jauch,et al.  Surgery and transplantation – Guidelines on Parenteral Nutrition, Chapter 18 , 2009, German medical science : GMS e-journal.

[21]  A. Hölscher,et al.  Early Gastric Cancer: Lymph Node Metastasis Starts With Deep Mucosal Infiltration , 2009, Annals of surgery.

[22]  A. Nashimoto,et al.  [Evaluation of hepatic resection for synchronous liver metastasis from gastric cancer]. , 2009, Gan to kagaku ryoho. Cancer & chemotherapy.

[23]  W. Allum,et al.  Long-term results of a randomized trial of surgery with or without preoperative chemotherapy in esophageal cancer. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[24]  Yiping Wang,et al.  Endoscopic mucosal resection for early gastric cancer. , 2009, The Cochrane database of systematic reviews.

[25]  N. Uedo,et al.  Endoscopic submucosal dissection for early gastric cancer performed by supervised residents: assessment of feasibility and learning curve* , 2009, Endoscopy.

[26]  F. Lordick,et al.  Cetuximab plus cisplatin-5-fluorouracil versus cisplatin-5-fluorouracil alone in first-line metastatic squamous cell carcinoma of the esophagus: a randomized phase II study of the Arbeitsgemeinschaft Internistische Onkologie. , 2009, Annals of oncology : official journal of the European Society for Medical Oncology.

[27]  F. Zaccagna,et al.  Diagnostic performance of 64-MDCT and 1.5-T MRI with highresolution sequences in the T staging of gastric cancer: a comparative analysis with histopathology , 2009, La radiologia medica.

[28]  E. Fukuda,et al.  Clinical Outcomes of Endoscopic Submucosal Dissection for Early Gastric Cancer by Indication Criteria , 2009, Digestion.

[29]  S. Ikeda,et al.  Safety and efficacy of bidirectional chemotherapy for treatment of patients with peritoneal dissemination from gastric cancer: Selection for cytoreductive surgery , 2009, Journal of surgical oncology.

[30]  D. August,et al.  A.S.P.E.N. clinical guidelines: nutrition support therapy during adult anticancer treatment and in hematopoietic cell transplantation. , 2009, JPEN. Journal of parenteral and enteral nutrition.

[31]  A. Norman,et al.  Meta-analysis of the REAL-2 and ML17032 trials: evaluating capecitabine-based combination chemotherapy and infused 5-fluorouracil-based combination chemotherapy for the treatment of advanced oesophago-gastric cancer. , 2009, Annals of oncology : official journal of the European Society for Medical Oncology.

[32]  R. Wesolowski,et al.  Is there a role for second-line chemotherapy in advanced gastric cancer? , 2009, The Lancet. Oncology.

[33]  Murielle Mauer,et al.  Baseline quality of life as a prognostic indicator of survival: a meta-analysis of individual patient data from EORTC clinical trials. , 2009, The Lancet. Oncology.

[34]  L. Collette,et al.  EORTC-ROG expert opinion: radiotherapy volume and treatment guidelines for neoadjuvant radiation of adenocarcinomas of the gastroesophageal junction and the stomach. , 2009, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[35]  H. Baba,et al.  Extensive Intraoperative Peritoneal Lavage as a Standard Prophylactic Strategy for Peritoneal Recurrence in Patients with Gastric Carcinoma , 2009, Annals of surgery.

[36]  G. La Torre,et al.  Survival after radiotherapy in gastric cancer: systematic review and meta-analysis. , 2009, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[37]  M. Moehler,et al.  Development of targeted therapies in advanced gastric cancer: promising exploratory steps in a new era , 2009, Current opinion in oncology.

[38]  P. Pauli,et al.  Effectiveness of education for gastric cancer patients: a controlled prospective trial comparing interactive vs. lecture-based programs. , 2009, Patient education and counseling.

[39]  J. Choi,et al.  Detecting recurrence of gastric cancer: the value of FDG PET/CT , 2009, Abdominal Imaging.

[40]  E. Van Cutsem,et al.  Efficacy results from the ToGA trial: A phase III study of trastuzumab added to standard chemotherapy (CT) in first-line human epidermal growth factor receptor 2 (HER2)-positive advanced gastric cancer (GC). , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[41]  F. Bozzetti,et al.  Nutritional support and tumour growth in humans: a narrative review of the literature. , 2009, Clinical nutrition.

[42]  N. Yahagi,et al.  Benefits of endoscopic submucosal dissection according to size and location of gastric neoplasm, compared with conventional mucosal resection , 2009, Journal of gastroenterology and hepatology.

[43]  E. Van Cutsem,et al.  Pathological features of advanced gastric cancer (GC): Relationship to human epidermal growth factor receptor 2 (HER2) positivity in the global screening programme of the ToGA trial. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[44]  A. Hinke,et al.  Irinotecan versus best supportive care (BSC) as second-line therapy in gastric cancer: A randomized phase III study of the Arbeitsgemeinschaft Internistische Onkologie (AIO). , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[45]  C. Pukall,et al.  An evidence‐based review of yoga as a complementary intervention for patients with cancer , 2009, Psycho-oncology.

[46]  R. van Haselen,et al.  Homeopathic medicines for adverse effects of cancer treatments. , 2009, The Cochrane database of systematic reviews.

[47]  Yoon-Koo Kang,et al.  Capecitabine/cisplatin versus 5-fluorouracil/cisplatin as first-line therapy in patients with advanced gastric cancer: a randomised phase III noninferiority trial. , 2009, Annals of oncology : official journal of the European Society for Medical Oncology.

[48]  A. Kiss,et al.  Endoscopic Ultrasound Versus CT Scan for Detection of the Metastases to the Liver: Results of a Prospective Comparative Study , 2009, Journal of clinical gastroenterology.

[49]  K. Chayama,et al.  Usefulness of Endoscopic Ultrasonography in Determining the Depth of Invasion and Indication for Endoscopic Treatment of Early Gastric Cancer , 2009, Journal of clinical gastroenterology.

[50]  M. Asaka,et al.  Effects of preoperative administration of omeprazole on bleeding after endoscopic submucosal dissection: a prospective randomized controlled trial. , 2009, Endoscopy.

[51]  M. Stuschke,et al.  Phase III comparison of preoperative chemotherapy compared with chemoradiotherapy in patients with locally advanced adenocarcinoma of the esophagogastric junction. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[52]  J. Itami,et al.  Palliative radiation therapy for hemorrhage of unresectable gastric cancer: a single institute experience , 2009, Journal of Cancer Research and Clinical Oncology.

[53]  M. Omata,et al.  Outcomes of endoscopic submucosal dissection for early gastric cancer with special reference to validation for curability criteria , 2009, Endoscopy.

[54]  M. Shah,et al.  Endoscopic ultrasound can improve the selection for laparoscopy in patients with localized gastric cancer. , 2009, Journal of the American College of Surgeons.

[55]  Y. Dittmar,et al.  [Indications and results of palliative gastric resection in advanced gastric carcinoma]. , 2009, Zentralblatt fur Chirurgie.

[56]  S. Bojesen,et al.  Elevated plasma YKL-40 predicts increased risk of gastrointestinal cancer and decreased survival after any cancer diagnosis in the general population. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[57]  H. Messmann,et al.  Endoscopic submucosal dissection of early cancers, flat adenomas, and submucosal tumors in the gastrointestinal tract. , 2009, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[58]  C. Bokemeyer,et al.  Four consecutive multicenter phase II trials of adjuvant chemoradiation in patients with completely resected high-risk gastric cancer: the experience of the German AIO/ARO/CAO group , 2009, Journal of Cancer Research and Clinical Oncology.

[59]  D. Ziogas,et al.  Is There a Role for Surgery in Recurrent Gastric Cancer , 2009, Annals of Surgical Oncology.

[60]  N. Uedo,et al.  Comparison of EMR and endoscopic submucosal dissection for en bloc resection of early esophageal cancers in Japan. , 2008, Gastrointestinal endoscopy.

[61]  T. Gotoda,et al.  Treatment strategy after non‐curative endoscopic resection of early gastric cancer , 2008, The British journal of surgery.

[62]  E. Fukuda,et al.  Endoscopic submucosal dissection for early gastric cancer: a large-scale feasibility study , 2008, Gut.

[63]  R. Hofheinz,et al.  Biweekly fluorouracil, leucovorin, oxaliplatin, and docetaxel (FLOT) for patients with metastatic adenocarcinoma of the stomach or esophagogastric junction: a phase II trial of the Arbeitsgemeinschaft Internistische Onkologie. , 2008, Annals of oncology : official journal of the European Society for Medical Oncology.

[64]  V. Catalano,et al.  Second-line chemotherapy for patients with advanced gastric cancer: who may benefit? , 2008, British Journal of Cancer.

[65]  S. Wilkinson,et al.  WITHDRAWN: Aromatherapy and massage for symptom relief in patients with cancer. , 2008, The Cochrane database of systematic reviews.

[66]  B. Xie,et al.  Randomized controlled trial of collaborative care management of depression among low-income patients with cancer. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[67]  K. Itani,et al.  Definitive risk factors for anastomotic leaks in elective open colorectal resection. , 2008, Archives of surgery.

[68]  S. Fukui,et al.  A randomized study assessing the efficacy of communication skill training on patients' psychologic distress and coping , 2008, Cancer.

[69]  P. Maingon,et al.  Prise en charge des adénocarcinomes de la jonction œsogastrique résécables : quel traitement périopératoire ? , 2008 .

[70]  L. Storey,et al.  Reflexology for Symptom Relief in Patients With Cancer , 2008, Cancer nursing.

[71]  G. Montgomery,et al.  Cancer-related fatigue: a systematic and meta-analytic review of non-pharmacological therapies for cancer patients. , 2008, Psychological bulletin.

[72]  G. Ji,et al.  Laparoscopically-assisted palliative total gastrectomy in patients with stage IV or metastatic gastric cancer: is it worthwhile? , 2008, Hepato-gastroenterology.

[73]  J. Zaluski,et al.  Randomized phase III study comparing irinotecan combined with 5-fluorouracil and folinic acid to cisplatin combined with 5-fluorouracil in chemotherapy naive patients with advanced adenocarcinoma of the stomach or esophagogastric junction. , 2008, Annals of oncology : official journal of the European Society for Medical Oncology.

[74]  G. Blackshaw,et al.  Prospective randomised clinical trial of providing patients with audiotape recordings of their oesophagogastric cancer consultations. , 2008, Patient education and counseling.

[75]  S. Kłęk,et al.  Standard and immunomodulating enteral nutrition in patients after extended gastrointestinal surgery--a prospective, randomized, controlled clinical trial. , 2008, Clinical nutrition.

[76]  B. Sergeyev,et al.  Postoperative change of anti-Thomsen-Friedenreich and Tn IgG level: the follow-up study of gastrointestinal cancer patients. , 2008, World journal of gastroenterology.

[77]  G. Murray,et al.  Management of depression for people with cancer (SMaRT oncology 1): a randomised trial , 2008, The Lancet.

[78]  K. Song,et al.  The role of surgery in the treatment of recurrent gastric cancer. , 2008, American journal of surgery.

[79]  H. Jim,et al.  Psychosocial Interventions for Anxiety and Depression in Adult Cancer Patients: Achievements and Challenges , 2008, CA: a cancer journal for clinicians.

[80]  T. Kwee,et al.  The Accuracy of Endoscopic Ultrasonography in Differentiating Mucosal from Deeper Gastric Cancer , 2008, The American Journal of Gastroenterology.

[81]  S. Mocellin,et al.  Recent advances in conventional and molecular prognostic factors for gastric carcinoma. , 2008, Surgical oncology clinics of North America.

[82]  Janice Sorensen,et al.  EuroOOPS: an international, multicentre study to implement nutritional risk screening and evaluate clinical outcome. , 2008, Clinical nutrition.

[83]  I. Choi,et al.  Endoscopic ultrasound and computed tomography in restaging and predicting prognosis after neoadjuvant chemotherapy in patients with locally advanced gastric cancer , 2008, Cancer.

[84]  T. Ohtsuka,et al.  Different Roles of Tumor Marker Monitoring after Curative Resections of Gastric and Colorectal Cancers , 2008, Digestive Diseases and Sciences.

[85]  J. Roh,et al.  Survival benefit of combined curative resection of the stomach (D2 resection) and liver in gastric cancer patients with liver metastases. , 2008, Annals of oncology : official journal of the European Society for Medical Oncology.

[86]  D. Razavi,et al.  Factors that influence cancer patients' and relatives' anxiety following a three‐person medical consultation: impact of a communication skills training program for physicians , 2008, Psycho-oncology.

[87]  M. Aapro,et al.  September 2007 update on EORTC guidelines and anemia management with erythropoiesis-stimulating agents. , 2008, The oncologist.

[88]  C. Bokemeyer,et al.  Erythropoietins should be used according to guidelines. , 2008, The Lancet. Oncology.

[89]  J. Ajani,et al.  Chemoradiation therapy for potentially resectable gastric cancer: clinical outcomes among patients who do not undergo planned surgery. , 2008, International journal of radiation oncology, biology, physics.

[90]  K. Linde,et al.  Mistletoe therapy in oncology. , 2008, The Cochrane database of systematic reviews.

[91]  B. Keum,et al.  Therapeutic outcomes in 1000 cases of endoscopic submucosal dissection for early gastric neoplasms: Korean ESD Study Group multicenter study. , 2008, Gastrointestinal endoscopy.

[92]  L. Gossner,et al.  Long-Term Results of Endoscopic Resection in Early Gastric Cancer: The Western Experience , 2008, The American Journal of Gastroenterology.

[93]  H. Ortiz,et al.  Surgical treatment of recurrent gastric cancer , 2008, Gastric Cancer.

[94]  H. Feußner,et al.  Endoskopische Resektion und minimal-invasive Verfahren beim Magenkarzinom , 2008, Der Onkologe.

[95]  C. Bokemeyer,et al.  Phase III trial in metastatic gastroesophageal adenocarcinoma with fluorouracil, leucovorin plus either oxaliplatin or cisplatin: a study of the Arbeitsgemeinschaft Internistische Onkologie. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[96]  C. Gotay,et al.  The prognostic significance of patient-reported outcomes in cancer clinical trials. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[97]  D. Sugarbaker,et al.  Phase III trial of trimodality therapy with cisplatin, fluorouracil, radiotherapy, and surgery compared with surgery alone for esophageal cancer: CALGB 9781. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[98]  Masahiro Takeuchi,et al.  S-1 plus cisplatin versus S-1 alone for first-line treatment of advanced gastric cancer (SPIRITS trial): a phase III trial. , 2008, The Lancet. Oncology.

[99]  D. Steensma.  Is anemia of cancer different from chemotherapy-induced anemia? , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[100]  N. Uedo,et al.  [Endoscopic resection for early gastric cancer--JGCA gastric cancer treatment guidelines and indications for endoscopic resection]. , 2008, Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology.

[101]  H. Shimada,et al.  Impact of palliative gastrectomy in patients with incurable advanced gastric cancer. , 2008, Anticancer research.

[102]  T. Gotoda,et al.  Clinical impact of endoscopic submucosal dissection for superficial adenocarcinoma located at the esophagogastric junction. , 2008, Gastrointestinal endoscopy.

[103]  R. Mason,et al.  A large series, resection controlled study to assess the value of radial EUS in restaging gastroesophageal cancer following neoadjuvant chemotherapy. , 2008, Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus.

[104]  A. Norman,et al.  Capecitabine and oxaliplatin for advanced esophagogastric cancer. , 2008, The New England journal of medicine.

[105]  H. Yanai,et al.  Ulcerous Change Decreases the Accuracy of Endoscopic Ultrasonography Diagnosis for the Invasive Depth of Early Gastric Cancer , 2007, International journal of gastrointestinal cancer.

[106]  S. Choi,et al.  A Prospective Randomized Trial of Either Famotidine or Pantoprazole for the Prevention of Bleeding after Endoscopic Submucosal Dissection , 2007, Journal of Korean Medical Science.

[107]  C. Bokemeyer,et al.  Renal toxicity of adjuvant chemoradiotherapy with cisplatin in gastric cancer. , 2007, International journal of radiation oncology, biology, physics.

[108]  B. So,et al.  Value of intensive follow‐up of patients after curative surgery for gastric carcinoma , 2007, Journal of surgical oncology.

[109]  M. Keller,et al.  Psychoonkologisches Screening in der Routineversorgung , 2007 .

[110]  H. Nagendra,et al.  Effects of an integrated yoga programme on chemotherapy-induced nausea and emesis in breast cancer patients. , 2007, European journal of cancer care.

[111]  Y. Seto,et al.  Liver resection for metastatic gastric cancer: experience with 42 patients including eight long-term survivors. , 2007, Japanese journal of clinical oncology.

[112]  Y. Youn,et al.  Clinicopathologic factors influence accurate endosonographic assessment for early gastric cancer. , 2007, Gastrointestinal endoscopy.

[113]  H. Lippert,et al.  A Multicentre Phase II Study of Docetaxel plus Cisplatin for the Treatment of Advanced Gastric Cancer , 2007, Chemotherapy.

[114]  S. Block,et al.  Psychiatric disorders in advanced cancer , 2007, Cancer.

[115]  F. Lordick,et al.  Split-dose docetaxel, cisplatin and leucovorin/fluorouracil as first-line therapy in advanced gastric cancer and adenocarcinoma of the gastroesophageal junction: results of a phase II trial. , 2007, Annals of oncology : official journal of the European Society for Medical Oncology.

[116]  V. Rusch,et al.  Endoscopic ultrasound predicts outcomes for patients with adenocarcinoma of the gastroesophageal junction. , 2007, Journal of the American College of Surgeons.

[117]  H. Joensuu,et al.  Lactobacillus supplementation for diarrhoea related to chemotherapy of colorectal cancer: a randomised study , 2007, British Journal of Cancer.

[118]  X. Mariette,et al.  Low dose interferon-alpha to treat Behçet's disease. , 2007, Clinical and experimental rheumatology.

[119]  Wolfgang A Weber,et al.  PET to assess early metabolic response and to guide treatment of adenocarcinoma of the oesophagogastric junction: the MUNICON phase II trial. , 2007, The Lancet. Oncology.

[120]  H. Schmoll,et al.  Guidelines for antiemetic treatment of chemotherapy-induced nausea and vomiting: past, present, and future recommendations. , 2007, The oncologist.

[121]  Jeffrey S. Morris,et al.  Clinical stage after preoperative chemoradiation is a better predictor of patient outcome than the baseline stage for localized gastric cancer , 2007, Cancer.

[122]  J. Ajani,et al.  Long-term results of RTOG trial 8911 (USA Intergroup 113): a random assignment trial comparison of chemotherapy followed by surgery compared with surgery alone for esophageal cancer. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[123]  K. Rufibach,et al.  Docetaxel, cisplatin, and fluorouracil; docetaxel and cisplatin; and epirubicin, cisplatin, and fluorouracil as systemic treatment for advanced gastric carcinoma: a randomized phase II trial of the Swiss Group for Clinical Cancer Research. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[124]  H. Ono,et al.  Gastric perforation during endoscopic resection for gastric carcinoma and the risk of peritoneal dissemination , 2007, The British journal of surgery.

[125]  D. Ilson.  Docetaxel, cisplatin, and fluorouracil in gastric cancer: does the punishment fit the crime? , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[126]  N. Uedo,et al.  Effect of a Proton Pump Inhibitor or an H2-Receptor Antagonist on Prevention of Bleeding From Ulcer After Endoscopic Submucosal Dissection of Early Gastric Cancer: A Prospective Randomized Controlled Trial , 2007, The American Journal of Gastroenterology.

[127]  D. Morris,et al.  A Systematic Review and Meta-analysis of the Randomized Controlled Trials on Adjuvant Intraperitoneal Chemotherapy for Resectable Gastric Cancer , 2007, Annals of Surgical Oncology.

[128]  S. Kitano,et al.  Multivariate prognostic study on large gastric cancer , 2007, Journal of surgical oncology.

[129]  K. Chayama,et al.  Endoscopic submucosal dissection for colorectal neoplasia: possibility of standardization. , 2007, Gastrointestinal endoscopy.

[130]  E. Van Cutsem,et al.  Weekly infusional high-dose fluorouracil (HD-FU), HD-FU plus folinic acid (HD-FU/FA), or HD-FU/FA plus biweekly cisplatin in advanced gastric cancer: randomized phase II trial 40953 of the European Organisation for Research and Treatment of Cancer Gastrointestinal Group and the Arbeitsgemeinschaft I , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[131]  A. L. Maître,et al.  Individual patient data-based meta-analysis assessing pre-operative chemotherapy in resectable oesophageal carcinoma , 2007 .

[132]  J. Pignon,et al.  Final results of a randomized trial comparing preoperative 5-fluorouracil (F)/cisplatin (P) to surgery alone in adenocarcinoma of stomach and lower esophagus (ASLE): FNLCC ACCORD07-FFCD 9703 trial , 2007 .

[133]  E. Steyerberg,et al.  Stent versus gastrojejunostomy for the palliation of gastric outlet obstruction: a systematic review , 2007, BMC gastroenterology.

[134]  H. Katai,et al.  Favorable indications for hepatectomy in patients with liver metastasis from gastric cancer , 2007, Journal of surgical oncology.

[135]  D. Germano,et al.  Reduced dose intensity of docetaxel plus capecitabine as second-line palliative chemotherapy in patients with metastatic gastric cancer: a phase II study. , 2007, Annals of oncology : official journal of the European Society for Medical Oncology.

[136]  J. Leblanc,et al.  Endoscopic ultrasound-guided fine-needle aspiration of ascites. , 2007, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[137]  P. García-Peris,et al.  N-3 fatty acids, cancer and cachexia: a systematic review of the literature. , 2007, The British journal of nutrition.

[138]  H. Ohtani,et al.  Endoscopic stenting versus surgical gastroenterostomy for palliation of malignant gastroduodenal obstruction: a meta-analysis , 2007, Journal of Gastroenterology.

[139]  D. Tripathy,et al.  Chinese medicinal herbs to treat the side-effects of chemotherapy in breast cancer patients. , 2007, The Cochrane database of systematic reviews.

[140]  Laura H. Tang,et al.  Clinical Correlation of Endoscopic Ultrasonography with Pathologic Stage and Outcome in Patients Undergoing Curative Resection for Gastric Cancer , 2007, Annals of Surgical Oncology.

[141]  Val Gebski,et al.  Survival benefits from neoadjuvant chemoradiotherapy or chemotherapy in oesophageal carcinoma: a meta-analysis. , 2007, The Lancet. Oncology.

[142]  K. Olson,et al.  Pilot Crossover Trial of Reiki Versus Rest for Treating Cancer-Related Fatigue , 2007, Integrative cancer therapies.

[143]  C. Loprinzi,et al.  A Critical Review of Complementary Therapies for Cancer-Related Fatigue , 2007, Integrative cancer therapies.

[144]  T. Gotoda.  Endoscopic resection of early gastric cancer , 2007, Gastric Cancer.

[145]  S. Ishikawa,et al.  Indications for EMR/ESD in cases of early gastric cancer: relationship between histological type, depth of wall invasion, and lymph node metastasis , 2007, Gastric Cancer.

[146]  J. Tey,et al.  The role of palliative radiation therapy in symptomatic locally advanced gastric cancer. , 2007, International journal of radiation oncology, biology, physics.

[147]  R. Berman,et al.  Results following resection for stage IV gastric cancer; are better outcomes observed in selected patient subgroups? , 2007, Journal of surgical oncology.

[148]  B. Higgins,et al.  Eicosapentaenoic acid (EPA, an omega-3 fatty acid from fish oils) for the treatment of cancer cachexia. , 2007, The Cochrane database of systematic reviews.

[149]  Hiroshi Ohtani,et al.  Meta-analysis of short-term outcomes after laparoscopy-assisted distal gastrectomy. , 2006, World journal of gastroenterology.

[150]  S. Paterson-Brown,et al.  The multidisciplinary team meeting improves staging accuracy and treatment selection for gastro-esophageal cancer. , 2006, Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus.

[151]  Glyn Elwyn,et al.  Inside the black box of shared decision making: distinguishing between the process of involvement and who makes the decision , 2006, Health expectations : an international journal of public participation in health care and health policy.

[152]  M. Hünerbein,et al.  Surgical strategies for gastric cancer with synchronous peritoneal carcinomatosis , 2006, The British journal of surgery.

[153]  S. Boccia,et al.  Response to neoadjuvant chemotherapy and effects of tumor regression in gastric cancer. , 2006, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[154]  A. Bardia,et al.  Efficacy of complementary and alternative medicine therapies in relieving cancer pain: a systematic review. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[155]  H. Inoue,et al.  A multicenter retrospective study of endoscopic resection for early gastric cancer , 2006, Gastric Cancer.

[156]  Daniel F Hayes,et al.  ASCO 2006 update of recommendations for the use of tumor markers in gastrointestinal cancer. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[157]  J. Ajani,et al.  Phase III study of docetaxel and cisplatin plus fluorouracil compared with cisplatin and fluorouracil as first-line therapy for advanced gastric cancer: a report of the V325 Study Group. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[158]  Yoshiyuki Watanabe,et al.  Safer endoscopic gastric mucosal resection: Preoperative proton pump inhibitor administration , 2006, Journal of gastroenterology and hepatology.

[159]  S. Choi,et al.  Early Postoperative Intraperitoneal Chemotherapy Following Cytoreductive Surgery in Patients with Very Advanced Gastric Cancer , 2006, Annals of Surgical Oncology.

[160]  A. Mehnert,et al.  Die deutsche Version des NCCN Distress-Thermometers , 2006 .

[161]  D. Lobo,et al.  Early postoperative jejunostomy feeding with an immune modulating diet in patients undergoing resectional surgery for upper gastrointestinal cancer: a prospective, randomized, controlled, double-blind study. , 2006, Clinical nutrition.

[162]  Andrea May,et al.  The Impact of Endoscopic Ultrasound and Computed Tomography on the TNM Staging of Early Cancer in Barrett's Esophagus , 2006, The American Journal of Gastroenterology.

[163]  M. Omata,et al.  A learning curve for endoscopic submucosal dissection of gastric epithelial neoplasms , 2006, Endoscopy.

[164]  K. Chayama,et al.  Endoscopic submucosal dissection for residual/local recurrence of early gastric cancer after endoscopic mucosal resection , 2006, Endoscopy.

[165]  W. Qureshi,et al.  Role of Serum Tumor Markers in Monitoring for Recurrence of Gastric Cancer Following Radical Gastrectomy , 2006, Digestive Diseases and Sciences.

[166]  J. Izbicki,et al.  Lymphatic spread and microinvolvement in adenocarcinoma of the esophago‐gastric junction , 2006, Journal of surgical oncology.

[167]  H. Jung,et al.  Omeprazole may be superior to famotidine in the management of iatrogenic ulcer after endoscopic mucosal resection: a prospective randomized controlled trial , 2006, Alimentary pharmacology & therapeutics.

[168]  A. Argyriou,et al.  Preventing paclitaxel-induced peripheral neuropathy: a phase II trial of vitamin E supplementation. , 2006, Journal of pain and symptom management.

[169]  J. Ajani,et al.  Phase II trial of preoperative chemoradiation in patients with localized gastric adenocarcinoma (RTOG 9904): quality of combined modality therapy and pathologic response. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[170]  Dorothee Volkert,et al.  The German hospital malnutrition study. , 2006, Clinical nutrition.

[171]  T. Gotoda,et al.  Endoscopic submucosal dissection allows curative resection of locally recurrent early gastric cancer after prior endoscopic mucosal resection. , 2006, Gastrointestinal endoscopy.

[172]  G. Dennert,et al.  Selenium for alleviating the side effects of chemotherapy, radiotherapy and surgery in cancer patients. , 2006, The Cochrane database of systematic reviews.

[173]  C. V. D. van de Velde,et al.  Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer. , 2006, The New England journal of medicine.

[174]  J. Verweij,et al.  Complementary and alternative medicine during cancer treatment: beyond innocence. , 2006, The oncologist.

[175]  J. Haerting,et al.  Chemotherapy in advanced gastric cancer: a systematic review and meta-analysis based on aggregate data. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[176]  M. Kris,et al.  American Society of Clinical Oncology guideline for antiemetics in oncology: update 2006. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[177]  S. Bauer-Wu,et al.  Mindfulness Meditation for Oncology Patients: A Discussion and Critical Review , 2006, Integrative cancer therapies.

[178]  J. Weis,et al.  Interventionen in der Rehabilitation von Mammakarzinompatientinnen - Eine methodenkritische Übersicht zum Forschungsstand , 2006 .

[179]  E. Kuipers,et al.  Staging of esophageal carcinoma in a low-volume EUS center compared with reported results from high-volume centers. , 2006, Gastrointestinal endoscopy.

[180]  J. Reynolds,et al.  Post-oesophagectomy early enteral nutrition via a needle catheter jejunostomy: 8-year experience at a specialist unit. , 2006, Clinical nutrition.

[181]  R. Labianca,et al.  The neo-adjuvant, surgical and adjuvant treatment of gastric adenocarcinoma. Current expert opinion derived from the Seventh World Congress on Gastrointestinal Cancer, Barcelona, 2005. , 2006, Annals of oncology : official journal of the European Society for Medical Oncology.

[182]  S. Post,et al.  Retraction: The Influence of Early Supplementation of Parenteral Nutrition on Quality of Life and Body Composition in Patients With Advanced Cancer. , 2006, JPEN. Journal of parenteral and enteral nutrition.

[183]  M. Mizuguchi,et al.  Clinical outcomes of EMR for gastric tumors: historical pilot evaluation between endoscopic submucosal dissection and conventional mucosal resection. , 2006, Gastrointestinal endoscopy.

[184]  T. Hickish,et al.  Efficacy and tolerability of chemotherapy in elderly patients with advanced oesophago-gastric cancer: A pooled analysis of three clinical trials. , 2006, European journal of cancer.

[185]  A. Argyriou,et al.  A randomized controlled trial evaluating the efficacy and safety of vitamin E supplementation for protection against cisplatin-induced peripheral neuropathy: final results , 2006, Supportive Care in Cancer.

[186]  M. Braga,et al.  ESPEN Guidelines on Enteral Nutrition: Surgery including organ transplantation. , 2006, Clinical nutrition.

[187]  S. Daneault,et al.  [Does meditation improve the quality of life for patients living with cancer?]. , 2006, Canadian family physician Medecin de famille canadien.

[188]  K. Shirabe,et al.  Hepatic resection for the treatment of liver metastases in gastric carcinoma: review of the literature. , 2006, HPB : the official journal of the International Hepato Pancreato Biliary Association.

[189]  Ichiro Oda,et al.  Complete endoscopic closure of gastric perforation induced by endoscopic resection of early gastric cancer using endoclips can prevent surgery (with video). , 2006, Gastrointestinal endoscopy.

[190]  G. Bodoky,et al.  ESPEN Guidelines on Enteral Nutrition: Non-surgical oncology. , 2006, Clinical nutrition.

[191]  S. Bentzen,et al.  Systematic overview of preoperative (neoadjuvant) chemoradiotherapy trials in oesophageal cancer: evidence of a radiation and chemotherapy dose response. , 2006, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[192]  M. Feuerstein,et al.  Psychosocial Interventions for Depression, Anxiety, and Quality of Life in Cancer Survivors: Meta-Analyses , 2006, International journal of psychiatry in medicine.

[193]  J. Dale,et al.  The effectiveness of treatment for depression/depressive symptoms in adults with cancer: a systematic review , 2006, British Journal of Cancer.

[194]  G. Rogers,et al.  Clinical Impact of Conventional Endosonography and Endoscopic Ultrasound-guided Fine-needle Aspiration in the Assessment of Patients with Barrett’s Esophagus and High-grade Dysplasia or Intramucosal Carcinoma who have been Referred for Endoscopic Ablation Therapy , 2006, Endoscopy.

[195]  J. So,et al.  Endoscopic ultrasonography for gastric cancer , 2006, Surgical Endoscopy And Other Interventional Techniques.

[196]  Gianni Tognoni,et al.  Aspirin for the Primary Prevention of Cardiovascular Events in Women and Men: A Sex-Specific Meta-Analysis of Randomized Controlled Trials , 2006, JAMA.

[197]  Joon-Oh Park,et al.  An observational study suggesting clinical benefit for adjuvant postoperative chemoradiation in a population of over 500 cases after gastric resection with D2 nodal dissection for adenocarcinoma of the stomach. , 2005, International journal of radiation oncology, biology, physics.

[198]  J. Richardson,et al.  Mindfulness-Based Stress Reduction as supportive therapy in cancer care: systematic review. , 2005, Journal of advanced nursing.

[199]  V. Sujendran,et al.  Needle catheter jejunostomy at esophagectomy for cancer , 2005, Journal of surgical oncology.

[200]  V. Gebski,et al.  Surgery alone versus chemoradiotherapy followed by surgery for resectable cancer of the oesophagus: a randomised controlled phase III trial. , 2005, The Lancet. Oncology.

[201]  R. Depalma,et al.  Determinants of Long-Term Survival After Major Surgery and the Adverse Effect of Postoperative Complications , 2005, Annals of surgery.

[202]  Ewout W Steyerberg,et al.  Stent placement or brachytherapy for palliation of dysphagia from esophageal cancer: a prognostic model to guide treatment selection. , 2005, Gastrointestinal endoscopy.

[203]  J. Roy,et al.  Randomized trial of antioxidant vitamins to prevent acute adverse effects of radiation therapy in head and neck cancer patients. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[204]  James B. Mitchell,et al.  Implications for tumor control during protection of normal tissues with antioxidants. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[205]  H. Lippert,et al.  Insufficiency risk of esophagojejunal anastomosis after total abdominal gastrectomy for gastric carcinoma , 2005, Langenbeck's Archives of Surgery.

[206]  H. Meyer.  The influence of case load and the extent of resection on the quality of treatment outcome in gastric cancer. , 2005, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[207]  C. Bokemeyer,et al.  Adjuvant chemoradiation using 5-fluorouracil/folinic acid/cisplatin with or without paclitaxel and radiation in patients with completely resected high-risk gastric cancer: two cooperative phase II studies of the AIO/ARO/ACO. , 2005, Annals of oncology : official journal of the European Society for Medical Oncology.

[208]  L. Lundell,et al.  Stent insertion or endoluminal brachytherapy as palliation of patients with advanced cancer of the esophagus and gastroesophageal junction. Results of a randomized, controlled clinical trial. , 2005, Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus.

[209]  Roy Soetikno,et al.  Endoscopic mucosal resection for early cancers of the upper gastrointestinal tract. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[210]  J. Bower,et al.  Yoga for cancer patients and survivors. , 2005, Cancer control : journal of the Moffitt Cancer Center.

[211]  H. D. de Haes,et al.  Communication in palliative care: a review of recent literature , 2005, Current opinion in oncology.

[212]  J. Keller,et al.  Human pancreatic exocrine response to nutrients in health and disease , 2005, Gut.

[213]  E. Hahn,et al.  Randomised phase II evaluation of irinotecan plus high-dose 5-fluorouracil and leucovorin (ILF) vs 5-fluorouracil, leucovorin, and etoposide (ELF) in untreated metastatic gastric cancer , 2005, British Journal of Cancer.

[214]  C. V. D. van de Velde,et al.  Status of extended lymph node dissection: Locoregional control is the only way to survive gastric cancer , 2005, Journal of surgical oncology.

[215]  M. Miura,et al.  A prospective randomized trial of either famotidine or omeprazole for the prevention of bleeding after endoscopic mucosal resection and the healing of endoscopic mucosal resection‐induced ulceration , 2005, Alimentary pharmacology & therapeutics.

[216]  L. Ho,et al.  Malignant mediastinal lymphadenopathy detected by staging EUS in patients with pancreaticobiliary cancer. , 2005, Gastrointestinal endoscopy.

[217]  Navtej S Buttar,et al.  American Gastroenterological Association technical review on the role of the gastroenterologist in the management of esophageal carcinoma. , 2005, Gastroenterology.

[218]  J. Roy,et al.  A randomized trial of antioxidant vitamins to prevent second primary cancers in head and neck cancer patients. , 2005, Journal of the National Cancer Institute.

[219]  W. Kirwan,et al.  Provider volume and outcomes for oncological procedures , 2005, The British journal of surgery.

[220]  T. Sohn,et al.  The role of follow-up endoscopy after total gastrectomy for gastric cancer. , 2005, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[221]  T. Kawamura,et al.  Treatment of peritoneal dissemination from gastric cancer by peritonectomy and chemohyperthermic peritoneal perfusion , 2005, The British journal of surgery.

[222]  U. Kleeberg,et al.  Patient satisfaction and quality of life in cancer outpatients: results of the PASQOC* study , 2005, Supportive Care in Cancer.

[223]  Cristiano G S Huscher,et al.  Laparoscopic Versus Open Subtotal Gastrectomy for Distal Gastric Cancer: Five-Year Results of a Randomized Prospective Trial , 2005, Annals of surgery.

[224]  A. Munro,et al.  Chinese medical herbs for chemotherapy side effects in colorectal cancer patients. , 2005, The Cochrane database of systematic reviews.

[225]  B. Dörken,et al.  Docetaxel and continuous-infusion fluorouracil versus epirubicin, cisplatin, and fluorouracil for advanced gastric adenocarcinoma: a randomized phase II study. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[226]  D. Arsène,et al.  Randomized multicenter phase II trial of a biweekly regimen of fluorouracil and leucovorin (LV5FU2), LV5FU2 plus cisplatin, or LV5FU2 plus irinotecan in patients with previously untreated metastatic gastric cancer: a Federation Francophone de Cancerologie Digestive Group Study--FFCD 9803. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[227]  M. Stuschke,et al.  Neoadjuvante Radiochemotherapie und Responseprädiktion , 2004, Der Onkologe.

[228]  E. Kuipers,et al.  Single-dose brachytherapy versus metal stent placement for the palliation of dysphagia from oesophageal cancer: multicentre randomised trial , 2004, The Lancet.

[229]  Joon-Oh Park,et al.  Docetaxel Plus Cisplatin as Second-Line Therapy in Metastatic or Recurrent Advanced Gastric Cancer Progressing on 5-Fluorouracil-Based Regimen , 2004, American journal of clinical oncology.

[230]  A. Bottomley,et al.  Clinical and psychometric validation of a questionnaire module, the EORTC QLQ-STO 22, to assess quality of life in patients with gastric cancer. , 2004, European journal of cancer.

[231]  R. Malthaner,et al.  Neoadjuvant or adjuvant therapy for resectable esophageal cancer: a systematic review and meta-analysis , 2004, BMC medicine.

[232]  J. Bensing,et al.  Psychosocial interventions for patients with advanced cancer – a systematic review of the literature , 2004, British Journal of Cancer.

[233]  T. Lehnert,et al.  Recognition of distress and psychiatric morbidity in cancer patients: a multi-method approach. , 2004, Annals of oncology : official journal of the European Society for Medical Oncology.

[234]  S. Choi,et al.  Survival benefit of metastasectomy for Krukenberg tumors from gastric cancer. , 2004, Gynecologic oncology.

[235]  R. Berardi,et al.  Molecular biology of sporadic gastric cancer: prognostic indicators and novel therapeutic approaches. , 2004, Cancer treatment reviews.

[236]  A. Norman,et al.  Multivariate prognostic factor analysis in locally advanced and metastatic esophago-gastric cancer--pooled analysis from three multicenter, randomized, controlled trials using individual patient data. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[237]  A. Venturi,et al.  Preoperative chemoradiotherapy for oesophageal cancer: a systematic review and meta-analysis , 2004, Gut.

[238]  D. Gouma,et al.  Extended lymph node dissection for gastric cancer: who may benefit? Final results of the randomized Dutch gastric cancer group trial. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[239]  R. Fouladi,et al.  Psychological adjustment and sleep quality in a randomized trial of the effects of a Tibetan yoga intervention in patients with lymphoma , 2004, Cancer.

[240]  J. D. Barry,et al.  Prospective comparison of D1 vs modified D2 gastrectomy for carcinoma , 2004, British Journal of Cancer.

[241]  K. Geisinger,et al.  Cytoreductive surgery with intraperitoneal hyperthermic chemotherapy for advanced gastric cancer , 2004, Journal of Gastrointestinal Surgery.

[242]  I. Bosaeus,et al.  Palliative nutritional intervention in addition to cyclooxygenase and erythropoietin treatment for patients with malignant disease: Effects on survival, metabolism, and function , 2004, Cancer.

[243]  T. Lehnert,et al.  Techniques of reconstruction after total gastrectomy for cancer , 2004, The British journal of surgery.

[244]  E Günter,et al.  Accuracy of staging in early oesophageal cancer using high resolution endoscopy and high resolution endosonography: a comparative, prospective, and blinded trial , 2004, Gut.

[245]  M. Morino,et al.  Survival results of a multicentre phase II study to evaluate D2 gastrectomy for gastric cancer , 2004, British Journal of Cancer.

[246]  Galina Velikova,et al.  Measuring quality of life in routine oncology practice improves communication and patient well-being: a randomized controlled trial. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[247]  D. Schadendorf,et al.  Final results of the EORTC 18871/DKG 80-1 randomised phase III trial. rIFN-alpha2b versus rIFN-gamma versus ISCADOR M versus observation after surgery in melanoma patients with either high-risk primary (thickness >3 mm) or regional lymph node metastasis. , 2004, European journal of cancer.

[248]  J. Kessler,et al.  DemTect: a new, sensitive cognitive screening test to support the diagnosis of mild cognitive impairment and early dementia , 2004, International journal of geriatric psychiatry.

[249]  L. Fallowfield,et al.  Communicating sad, bad, and difficult news in medicine , 2004, The Lancet.

[250]  A. House,et al.  Major depression in outpatients attending a regional cancer centre: screening and unmet treatment needs , 2004, British Journal of Cancer.

[251]  K. Savik,et al.  Therapeutic Massage and Healing Touch Improve Symptoms in Cancer , 2003, Integrative cancer therapies.

[252]  P. Sugarbaker,et al.  Gastrectomy, peritonectomy, and perioperative intraperitoneal chemotherapy: the evolution of treatment strategies for advanced gastric cancer. , 2003, Seminars in surgical oncology.

[253]  K. Schmidt,et al.  Mistletoe for cancer? , 2003, International journal of cancer.

[254]  S. Nag,et al.  Randomized prospective study comparing high-dose-rate intraluminal brachytherapy (HDRILBT) alone with HDRILBT and external beam radiotherapy in the palliation of advanced esophageal cancer. , 2003, Brachytherapy.

[255]  H. Höfler,et al.  Histomorphology and grading of regression in gastric carcinoma treated with neoadjuvant chemotherapy , 2003, Cancer.

[256]  A. Mushlin,et al.  Influence of Surgical Subspecialty Training on In-Hospital Mortality for Gastrectomy and Colectomy Patients , 2003, Annals of surgery.

[257]  Y. Maehara,et al.  Analysis of the prognostic factors for liver metastasis of gastric cancer after hepatic resection: a multi-institutional study of the indications for resection. , 2003, Hepato-gastroenterology.

[258]  T. Fujita,et al.  Circulating alpha-2-macroglobulin levels and depression scores in patients who underwent abdominal cancer surgery. , 2003, The Journal of surgical research.

[259]  J. Sakamoto,et al.  The usefulness of CEA and/or CA19-9 in monitoring for recurrence in gastric cancer patients: a prospective clinical study , 2003, Gastric Cancer.

[260]  D. Razavi,et al.  How to optimize physicians' communication skills in cancer care: results of a randomized study assessing the usefulness of posttraining consolidation workshops. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[261]  R. Pukrop,et al.  Effects of psychosocial interventions on quality of life in adult cancer patients: meta analysis of 37 published controlled outcome studies. , 2003, Patient education and counseling.

[262]  F. Gilly,et al.  Surgery combined with peritonectomy procedures and intraperitoneal chemohyperthermia in abdominal cancers with peritoneal carcinomatosis: a phase II study. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[263]  M. Nita,et al.  Extended versus limited lymph nodes dissection technique for adenocarcinoma of the stomach. , 2003, The Cochrane database of systematic reviews.

[264]  N. Aaronson,et al.  Health-related quality-of-life assessments and patient-physician communication: a randomized controlled trial. , 2002, JAMA.

[265]  T. Kaptchuk,et al.  Advising Patients Who Seek Complementary and Alternative Medical Therapies for Cancer , 2002, Annals of Internal Medicine.

[266]  K. Hizawa,et al.  Is Endoscopic Ultrasonography Indispensable in Assessing the Appropriateness of Endoscopic Resection for Gastric Cancer? , 2002, Endoscopy.

[267]  B. Glimelius,et al.  Chemotherapy in gastric cancer: a review and updated meta-analysis , 2002 .

[268]  H. Putter,et al.  Value of palliative resection in gastric cancer , 2002, The British journal of surgery.

[269]  T. Hickish,et al.  A multicentre, randomised phase III trial comparing protracted venous infusion (PVI) 5-fluorouracil (5-FU) with PVI 5-FU plus mitomycin C in patients with inoperable oesophago-gastric cancer. , 2002, Annals of oncology : official journal of the European Society for Medical Oncology.

[270]  Ethan A Halm,et al.  Is Volume Related to Outcome in Health Care? A Systematic Review and Methodologic Critique of the Literature , 2002, Annals of Internal Medicine.

[271]  G. Demetri,et al.  Relationship between changes in hemoglobin level and quality of life during chemotherapy in anemic cancer patients receiving epoetin alfa therapy , 2002, Cancer.

[272]  W. Allum,et al.  Guidelines for the management of oesophageal and gastric cancer , 2002, Gut.

[273]  L. Stassen,et al.  Hospital volume and post-operative mortality after resection for gastric cancer. , 2002, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[274]  M. Catalano,et al.  EUS-guided fine needle aspiration of the liver: indications, yield, and safety based on an international survey of 167 cases. , 2002, Gastrointestinal endoscopy.

[275]  M. Braga,et al.  A randomized controlled trial of preoperative oral supplementation with a specialized diet in patients with gastrointestinal cancer. , 2002, Gastroenterology.

[276]  H. Höfler,et al.  You get what you expect? A critical appraisal of imaging methodology in endosonographic cancer staging , 2002, Gut.

[277]  J. Urschel,et al.  A meta-analysis of randomized controlled trials that compared neoadjuvant chemoradiation and surgery to surgery alone for resectable esophageal cancer. , 2002, American journal of surgery.

[278]  S. Nag,et al.  Prospective randomized trial of HDR brachytherapy as a sole modality in palliation of advanced esophageal carcinoma--an International Atomic Energy Agency study. , 2001, International journal of radiation oncology, biology, physics.

[279]  J. Zalcberg,et al.  Randomized trial of coordinated psychosocial interventions based on patient self-assessments versus standard care to improve the psychosocial functioning of patients with cancer. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[280]  B. Dahme,et al.  The effectiveness of relaxation training in reducing treatment‐related symptoms and improving emotional adjustment in acute non‐surgical cancer treatment: a meta‐analytical review , 2001, Psycho-oncology.

[281]  T. Lipman,et al.  AGA technical review on parenteral nutrition. , 2001, Gastroenterology.

[282]  Scott A. Hundahl,et al.  Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction. , 2001, The New England journal of medicine.

[283]  L. Rubenstein,et al.  The Mini Nutritional Assessment-Short Form for preoperative nutritional evaluation of elderly patients , 2001, Aging.

[284]  H. Chung,et al.  Indications for Early Postoperative Intraperitoneal Chemotherapy of Advanced Gastric Cancer: Results of a Prospective Randomized Trial , 2001, World Journal of Surgery.

[285]  C. Hovendal,et al.  Clinical Impact of Endoscopic Ultrasound-Guided Fine Needle Aspiration Biopsy in Patients with Upper Gastrointestinal Tract Malignancies. A Prospective Study , 2001, Endoscopy.

[286]  L. Fallowfield,et al.  Psychiatric morbidity and its recognition by doctors in patients with cancer , 2001, British Journal of Cancer.

[287]  D. Heyland,et al.  Total parenteral nutrition in the surgical patient: a meta-analysis. , 2001, Canadian journal of surgery. Journal canadien de chirurgie.

[288]  J. Ajani,et al.  Postoperative combined radiation and chemotherapy improves disease-free survival (DFS) and overall survival (OS) in resected adenocarcinoma of the stomach and G.E. junction. Results of intergroup study INT-0116 (SWOG 9008) , 2001 .

[289]  L. Carlson,et al.  The effects of a mindfulness meditation-based stress reduction program on mood and symptoms of stress in cancer outpatients: 6-month follow-up , 2001, Supportive Care in Cancer.

[290]  M. Iannettoni,et al.  Randomized trial of preoperative chemoradiation versus surgery alone in patients with locoregional esophageal carcinoma. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[291]  H. Friess,et al.  Indication for Pancreatic Enzyme Substitution following Gastric Resection , 2001, Pancreatology.

[292]  W. Söllner,et al.  How successful are oncologists in identifying patient distress, perceived social support, and need for psychosocial counselling? , 2001, British Journal of Cancer.

[293]  Y. Nakanishi,et al.  Incidence of lymph node metastasis from early gastric cancer: estimation with a large number of cases at two large centers , 2000, Gastric Cancer.

[294]  R. Gelber,et al.  Quality-of-life scores predict outcome in metastatic but not early breast cancer. International Breast Cancer Study Group. , 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[295]  N. Soehendra,et al.  Mediastinal lymphadenopathy in patients with or without previous malignancy: EUS-FNA-based differential cytodiagnosis in 153 patients , 2000, American Journal of Gastroenterology.

[296]  F B Lammes,et al.  Doctor-patient communication and cancer patients' quality of life and satisfaction. , 2000, Patient education and counseling.

[297]  W. Hopfenmüller,et al.  Detection and prognosis of recurrent gastric cancer--is routine follow-up after gastrectomy worthwhile? , 2000, Hepato-gastroenterology.

[298]  L. Carlson,et al.  A Randomized, Wait-List Controlled Clinical Trial: The Effect of a Mindfulness Meditation-Based Stress Reduction Program on Mood and Symptoms of Stress in Cancer Outpatients , 2000, Psychosomatic medicine.

[299]  S. Barni,et al.  Efficacy of adjuvant chemotherapy after curative resection for gastric cancer: a meta-analysis of published randomised trials. A study of the GISCAD (Gruppo Italiano per lo Studio dei Carcinomi dell'Apparato Digerente). , 2000, Annals of oncology : official journal of the European Society for Medical Oncology.

[300]  A. Sgadari,et al.  Surgery: Independent Prognostic Factor in Curable and Far Advanced Gastric Cancer , 2000, World Journal of Surgery.

[301]  Weis Joachim,et al.  Psychoonkologische Versorgung in Deutschland: Qualität und Quantität/ Psychooncological care in Germany: Quality and quantity , 2000 .

[302]  H J Wanebo,et al.  Paclitaxel and concurrent radiation for gastric cancer. , 2000, International journal of radiation oncology, biology, physics.

[303]  P. Maguire,et al.  The effect of psychological interventions on anxiety and depression in cancer patients: results of two meta-analyses , 1999, British Journal of Cancer.

[304]  K. Hirose,et al.  Efficacy of Continuous Hyperthermic Peritoneal Perfusion for the Prophylaxis and Treatment of Peritoneal Metastasis of Advanced Gastric Cancer: Evaluation by Multivariate Regression Analysis , 1999, Oncology.

[305]  C. Earle,et al.  Adjuvant chemotherapy after curative resection for gastric cancer in non-Asian patients: revisiting a meta-analysis of randomised trials. , 1999, European journal of cancer.

[306]  M A Fujino,et al.  Accuracy of screening for gastric cancer using serum pepsinogen concentrations , 1999, Gut.

[307]  D. Gouma,et al.  Extended lymph-node dissection for gastric cancer. , 1999, The New England journal of medicine.

[308]  P. Fayers,et al.  Patient survival after D 1 and D 2 resections for gastric cancer: long-term results of the MRC randomized surgical trial , 1999, British Journal of Cancer.

[309]  J. Ajani,et al.  Chemotherapy followed by surgery compared with surgery alone for localized esophageal cancer. , 1998, The New England journal of medicine.

[310]  W. Yin,et al.  Randomized clinical trial on the combination of preoperative irradiation and surgery in the treatment of adenocarcinoma of gastric cardia (AGC)--report on 370 patients. , 1998, International journal of radiation oncology, biology, physics.

[311]  H. Nawata,et al.  Pretreatment staging of endoscopically early gastric cancer with a 15 MHz ultrasound catheter probe. , 1998, Gastrointestinal endoscopy.

[312]  Sallie Newell,et al.  How well do Medical oncologists' perceptions reflect their patients' reported physical and psychosocial problems? , 1998, Cancer.

[313]  J. Siewert,et al.  Relevant prognostic factors in gastric cancer: ten-year results of the German Gastric Cancer Study. , 1998, Annals of surgery.

[314]  J. Holland,et al.  Rapid screening for psychologic distress in men with prostate carcinoma , 1998, Cancer.

[315]  H. Allgayer,et al.  Prognostic factors in gastric cancer , 1997, The British journal of surgery.

[316]  R. Miceli,et al.  Total versus subtotal gastrectomy: surgical morbidity and mortality rates in a multicenter Italian randomized trial. The Italian Gastrointestinal Tumor Study Group. , 1997, Annals of surgery.

[317]  F. Grover,et al.  Risk adjustment of the postoperative mortality rate for the comparative assessment of the quality of surgical care: results of the National Veterans Affairs Surgical Risk Study. , 1997, Journal of the American College of Surgeons.

[318]  J. Bosset,et al.  Chemoradiotherapy followed by surgery compared with surgery alone in squamous-cell cancer of the esophagus. , 1997, The New England journal of medicine.

[319]  W. Browner,et al.  Case-finding instruments for depression , 1997, Journal of General Internal Medicine.

[320]  H. Nawata,et al.  Relationship between histological type and endosonographic detection of regional lymph node metastases in gastric cancer. , 1997, The British journal of radiology.

[321]  S. Fujimoto,et al.  Improved mortality rate of gastric carcinoma patients with peritoneal carcinomatosis treated with intraperitoneal hyperthermic chemoperfusion combined with surgery , 1997, Cancer.

[322]  U. Haglund,et al.  Randomized comparison between chemotherapy plus best supportive care with best supportive care in advanced gastric cancer. , 1997, Annals of oncology : official journal of the European Society for Medical Oncology.

[323]  T. Walsh,et al.  A comparison of multimodal therapy and surgery for esophageal adenocarcinoma. , 1996, The New England journal of medicine.

[324]  P. Malfertheiner,et al.  Maldigestion after total gastrectomy is associated with pancreatic insufficiency. , 1996, The American journal of gastroenterology.

[325]  M. Bullinger.  German translation and psychometric testing of the SF-36 Health Survey: preliminary results from the IQOLA Project. International Quality of Life Assessment. , 1995, Social science & medicine.

[326]  P. Hermanek.  pTNM and residual tumor classifications: Problems of assessment and prognostic significance , 1995, World Journal of Surgery.

[327]  T. Hickish,et al.  A phase II study in advanced gastro-esophageal cancer using epirubicin and cisplatin in combination with continuous infusion 5-fluorouracil (ECF). , 1994, Annals of oncology : official journal of the European Society for Medical Oncology.

[328]  T. Nikolaus,et al.  [Social aspects in diagnosis and therapy of very elderly patients. Initial experiences with a newly developed questionnaire within the scope of geriatric assessment]. , 1994, Zeitschrift fur Gerontologie.

[329]  N. Gebbia,et al.  A prospective randomized trial of thymopentin versus granulocyte--colony stimulating factor with or without thymopentin in the prevention of febrile episodes in cancer patients undergoing highly cytotoxic chemotherapy. , 1994, Anticancer research.

[330]  S. Birge,et al.  Clock Completion: An Objective Screening Test for Dementia , 1993, Journal of the American Geriatrics Society.

[331]  C. V. D. van de Velde,et al.  Adjuvant therapy after curative resection for gastric cancer: meta-analysis of randomized trials. , 1993, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[332]  A. Petroianu,et al.  Modified therapy with 5‐fluorouracil, doxorubicin, and methotrexate in advanced gastric cancer , 1993, Cancer.

[333]  D. Osoba,et al.  The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. , 1993, Journal of the National Cancer Institute.

[334]  D. Tulsky,et al.  The Functional Assessment of Cancer Therapy scale: development and validation of the general measure. , 1993, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[335]  R. Hatlevoll,et al.  Pre-operative radiotherapy prolongs survival in operable esophageal carcinoma: A randomized, multicenter study of pre-operative radiotherapy and chemotherapy. The second scandinavian trial in esophageal cancer , 1992, World Journal of Surgery.

[336]  M. Rothmund,et al.  Lymph node counts in the upper abdomen: Anatomical basis for lymphadenectomy in gastric cancer , 1991, The British journal of surgery.

[337]  Diane Podsiadlo,et al.  The Timed “Up & Go”: A Test of Basic Functional Mobility for Frail Elderly Persons , 1991, Journal of the American Geriatrics Society.

[338]  W. Allum,et al.  A controlled, prospective, randomised trial of adjuvant chemotherapy or radiotherapy in resectable gastric cancer: interim report. British Stomach Cancer Group. , 1989, British Journal of Cancer.

[339]  P. Petronella,et al.  [Thymopentin and immune response in patients with cancer]. , 1989, Minerva chirurgica.

[340]  M. Tinetti.  Performance‐Oriented Assessment of Mobility Problems in Elderly Patients , 1986, Journal of the American Geriatrics Society.

[341]  J. Filshie,et al.  Acupuncture and malignant pain problems. , 1985, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[342]  J. O'fallon,et al.  Combined 5-fluorouracil and radiation therapy as a surgical adjuvant for poor prognosis gastric carcinoma. , 1984, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[343]  P. Cheverton,et al.  Prospective randomized trial of combined oncological therapy for gastric carcinoma , 1979, Cancer.

[344]  L. Havelec,et al.  Rezidivprophylaxe bei operierten Bronchuskarzinompatienten mit dem Mistelpräparat Iscador® – Ergebnisse eines klinischen Versuchs aus den Jahren 1969–1971 , 1978 .

[345]  S. Folstein,et al.  “Mini-mental state”: A practical method for grading the cognitive state of patients for the clinician , 1975 .

[346]  M. Lawton,et al.  Assessment of older people: self-maintaining and instrumental activities of daily living. , 1969, The Gerontologist.

[347]  Mahoney Fi,et al.  FUNCTIONAL EVALUATION: THE BARTHEL INDEX. , 1965 .

[348]  M. Ebert,et al.  A randomized multicenter phase II study comparing capecitabine with irinotecan or cisplatin in metastatic adenocarcinoma of the stomach or esophagogastric junction. , 2010, Annals of oncology : official journal of the European Society for Medical Oncology.

[349]  J. Siewert,et al.  Praxis der Viszeralchirurgie Onkologische Chirurgie , 2010 .

[350]  H. Hur,et al.  Follow-Up Strategy After Curative Resection of Gastric Cancer: A Nationwide Survey in Korea , 2009, Annals of Surgical Oncology.

[351]  Hsiu‐Po Wang,et al.  Endoscopic submucosal dissection for gastric epithelial tumors: a multicenter study in Taiwan. , 2009, Journal of the Formosan Medical Association = Taiwan yi zhi.

[352]  Tetsuya Nakamura,et al.  Endoscopic submucosal dissection in 100 lesions with early gastric carcinoma. , 2009, Hepato-gastroenterology.

[353]  B. Feig,et al.  Attempted Salvage Resection for Recurrent Gastric or Gastroesophageal Cancer , 2008, Annals of Surgical Oncology.

[354]  E. Cho,et al.  Randomized phase II study of irinotecan, leucovorin and 5-fluorouracil (ILF) versus cisplatin plus ILF (PILF) combination chemotherapy for advanced gastric cancer. , 2008, Annals of oncology : official journal of the European Society for Medical Oncology.

[355]  C. Bokemeyer,et al.  EORTC guidelines for the use of erythropoietic proteins in anaemic patients with cancer: 2006 update. , 2007, European journal of cancer.

[356]  T. Ohtsuka,et al.  False-positive Findings for Tumor Markers after Curative Gastrectomy for Gastric Cancer , 2007, Digestive Diseases and Sciences.

[357]  J. Holland,et al.  The NCCN guideline for distress management: a case for making distress the sixth vital sign. , 2007, Journal of the National Comprehensive Cancer Network : JNCCN.

[358]  A. Favero,et al.  Prevention of chemotherapy- and radiotherapy-induced emesis: results of the 2004 Perugia International Antiemetic Consensus Conference. , 2006, Annals of oncology : official journal of the European Society for Medical Oncology.

[359]  N. Favre,et al.  Communication skills training in oncology: it works! , 2006, Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer.

[360]  J. Siewert,et al.  Praxis der Viszeralchirurgie , 2006 .

[361]  K. Van Steen,et al.  Does a patient's self-reported health-related quality of life predict survival beyond key biomedical data in advanced colorectal cancer? , 2006, European journal of cancer.

[362]  H. Katai,et al.  Follow-up of gastric cancer: a review , 2006, Gastric Cancer.

[363]  H. Tsukuma,et al.  Longterm outcomes after endoscopic mucosal resection for early gastric cancer , 2005, Gastric Cancer.

[364]  A. Weimann,et al.  Bedeutung des präoperativen Gewichtsverlusts für die perioperative Stoffwechseladaptation und das Operationsrisiko bei Patienten mit Tumoren im oberen Gastrointestinaltrakt , 2004, Langenbecks Archiv für Chirurgie.

[365]  L. Assersohn,et al.  Phase II study of irinotecan and 5-fluorouracil/leucovorin in patients with primary refractory or relapsed advanced oesophageal and gastric carcinoma. , 2004, Annals of oncology : official journal of the European Society for Medical Oncology.

[366]  E. Cotte,et al.  Cytoreductive surgery and intraperitoneal chemohyperthermia for peritoneal carcinomatosis arising from gastric cancer. , 2004, Archives of surgery.

[367]  L. Gianni,et al.  Adjuvant chemotherapy in gastric cancer: a meta-analysis of randomized trials and a comparison with previous meta-analyses. , 2002, Tumori.

[368]  Steven Piantadosi,et al.  The prevalence of psychological distress by cancer site , 2001, Psycho-oncology.

[369]  H. Höfler,et al.  [Morphologic response evaluation of neoadjuvant chemotherapy of gastric carcinoma]. , 2000, Verhandlungen der Deutschen Gesellschaft fur Pathologie.

[370]  J. Donohue,et al.  Results of irradiation or chemoirradiation for primary unresectable, locally recurrent, or grossly incomplete resection of gastric adenocarcinoma. , 2000, International journal of radiation oncology, biology, physics.

[371]  L. Mariani,et al.  Perioperative total parenteral nutrition in malnourished, gastrointestinal cancer patients: a randomized, clinical trial. , 2000, JPEN. Journal of parenteral and enteral nutrition.

[372]  R. Kim,et al.  An analysis of the therapeutic efficacy of protracted infusion of low-dose 5-fluorouracil and cisplatin in advanced gastric cancer , 2000, Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy.

[373]  R. Sanson-Fisher,et al.  The unmet supportive care needs of patients with cancer. Supportive Care Review Group. , 2000 .

[374]  R. Sanson-Fisher,et al.  The unmet supportive care needs of patients with cancer , 2000, Cancer.

[375]  R. Stockbrügger,et al.  The effect of pancreatic enzyme supplementation in patients with steatorrhoea after total gastrectomy. , 1999, European journal of gastroenterology & hepatology.

[376]  S. Lundgren,et al.  Comparison of toremifene and tamoxifen in post-menopausal patients with advanced breast cancer: a randomized double-blind, the 'nordic' phase III study. , 1997, British Journal of Cancer.

[377]  P. Sugarbaker,et al.  Clinical research methodologies in diagnosis and staging of patients with peritoneal carcinomatosis. , 1996, Cancer treatment and research.

[378]  H. Friess,et al.  Enzyme treatment after gastrointestinal surgery. , 1993, Digestion.

[379]  John E. Ware,et al.  SF-36 Health Survey. , 1990 .

[380]  P. Hermanek,et al.  The Significance of the Extent of Proximal Margins of Clearance in Gastric Cancer Surgery , 1987 .

[381]  V. Leirer,et al.  Development and validation of a geriatric depression screening scale: a preliminary report. , 1982, Journal of psychiatric research.